Endoscopic Treatment of Vesicoureteral Reflux

Vesicoureteral reflux(VUR), an abnormal movement of urine from the bladder into ureters or kidneys. It may present before birth as prenatal ureterohydronephrosis, an abnormal widening of the ureter, or with a urinary tract infection or acute pyelonephritis. Vesicoureteral reflux is estimated to occur in 1% to 3% of children. Younger children are more prone to Vesicoureteral reflux because of the relative shortness of the submucosal ureters. In children with Urinary Tract Infections, the incidence of VUR is 29% in boys and 14% in girls. Endoscopic treatment of vesicoureteral reflux can be recommended as a first-line therapy for most children with the cases of vesicoureteral reflux, because of the short hospital stay, absence of complications and the high success rate.

  • Track 1-1 Risks of the Procedure
  • Track 2-2 Side Effects of the Procedure
  • Track 3-3 Subureteral Dextranomer
  • Track 4-4 Hyaluronic acid copolymer injection

Related Conference of Nephrology